We studied Fe absorption from FeSO 4 in rats with Fe deficiency-induced anaemia that were given an Fe-sufflcient purified diet without or with ascorbic acid (10-4 g/kg diet). Attention was focused on mucosal Fe uptake as measured in vivo by a double-isotope technique. Haemoglobin repletion and liver Fe levels were not affected when the ascorbic acid-supplemented diet was given, but apparent Fe absorption and retention of orally administered 59 Fe were significantly enhanced. The distribution of Fe between liquid and solid phases of contents of both the stomach and the proximal intestine was not affected by the feeding of the ascorbic acid, but ascorbic acid significantly enhanced mucosal Fe uptake. It is concluded that ascorbic acid in the diet raises mucosal Fe uptake through a mechanism independent of the intestinal Fe solubility.
Ascorbic acid is a powerful enhancer of non-haem Fe absorption in man (Monsen, 1982; Hallberg et al. 1986 ). The mechanism of action of ascorbic acid is not yet fully clear. In the digesta, ascorbic acid may reduce ferric iron to the ferrous form (Bothwell et al. 1979) , which should raise Fe solubility (Van Gils et al. 1994 ) and thereby render Fe available for absorption in the proximal intestine. Alternatively, ascorbic acid may facilitate Fe absorption by forming with Fe a chelate that is soluble in the digesta (Bothwell et al. 1979; Lynch & Cook, 1980) , but this mechanism has been criticized (Plug et al. 1984) .
It is not known whether ascorbic acid has any effect on processes beyond intraluminal interaction, i.e. at the level of the microvillous mucosal membrane or within the enterocyte. Dietary modulators of Fe absorption could influence mucosal Fe uptake and/or mucosal transfer. For instance, we have shown in rats that CaCC>3 inhibits Fe absorption, at least partly, by reducing mucosal Fe transfer (Wienk et al. 1996) . In this present study we focused on the effect of dietary ascorbic acid on mucosal uptake of Fe. In keeping with our previous study (Wienk et al. 1996) we used as a model the anaemic rat being repleted with Fe.
MATERIALS AND METHODS
The experimental protocol was approved by the Animal Experiments Committee of the Department of Laboratory Animal Science, Utrecht University, The Netherlands.
Animals, housing and diets
Weanling, male Wistar U:WU(CPB) rats, aged about 3 weeks, were used. For 3 weeks the rats were housed in groups of four animals in wire-topped polycarbonate cages (Macrolon Type III, UNO B.V., Zevenaar, The Netherlands), containing a layer of Fe-free sawdust. Subsequently they were transferred to metabolism cages (Tecniplast Gazzada, Buguggiate, Italy) in which they were housed individually for the remaining 3 weeks of the study. All rats were housed in a room with controlled temperature (20-22°), relative humidity (40-65%) and lighting (12 h/d).
During the first 4 weeks the rats were fed on a pre-experimental, purified diet which was low in Fe in order to induce Fe-deficiency anaemia (Table 1) . While the rats were housed in groups they had free access to their diet. From the time-point of individual housing they were accustomed to a time-restricted feeding regimen. They had free access to feed, but only for 4 h/d (08.00-12.00 hours). Demineralized water was supplied ad libitum throughout the study. All animals were weighed weekly.
At the end of the 4-week pre-experimental period (day 0) the animals were divided into two groups of eight rats each, so that the group distributions of blood haemoglobin (Hb) and body weight were similar. Each group was fed on one of the two experimental, purified diets (Table 1) . The rats were assigned a randomized cage position. We supplied a control diet and an ascorbic acid-containing diet (10 g ascorbic acid/kg diet; L-ascorbic acid, Merck, Darmstadt, Germany). The diets were in powdered form, and stored at 4° until used for feeding. The experimental diets were made adequate in Fe by the addition of FeSO 4 .7H 2 O. Feed intake was recorded daily, and water intake was recorded during two 3 d balance periods (days 5-7 and 12-14) . The experimental period lasted for 15 d. Mineral and vitamin premixes are specified elsewhere (Wienk et al. 1996) .
Ascorbic acid analysis
Ascorbic acid was determined in the ascorbic-acid diet according to the method of Speek et al. (1984) .
Haemoglobin determination
On day 0 and day 15 of the experimental period, blood was withdrawn by orbital puncture while the rats were under light diethyl ether anaesthesia. About 0-8 ml blood was collected from each animal. Hb was determined using a haematology analyser (Sysmex K-1000, Toa Medical Electronics Co. Ltd, Kobe, Japan).
Iron analysis
Diets were wet-ashed in 14-3 M-HNO 3 and Fe was determined by flame atomic absorption spectrometry (Varian SpectrAA 250 Plus, Varian, Mulgrave Victoria, Australia Pty Ltd). Faeces were collected quantitatively for individual animals during the two 3 d balance periods (days 5-7 and 12-14) . Metabolism cages and excreta collection tubes were rinsed with 01 M-HC1 and demineralized water before use to prevent Fe contamination. Faeces were pooled for each rat during each balance period, dried (75°, 70 h), and dry-ashed (500°, 17 h). The ash was dissolved in 6 M-HC1 and Fe analysed in the resulting acid extracts using flame atomic absorption spectrometry.
On day 15 all rats received their diets with or without supplemental ascorbic acid at 10 min time intervals. Exactly 3 h after the start of feed supply, each rat was killed by cervical dislocation while under light diethyl ether anaesthesia. The stomach and the entire small intestine were removed. The latter was divided into proximal and distal halves. Digesta samples were collected in pre-weighed centrifuge tubes, weighed, and centrifuged (stomach digesta: 30 min, 40 000 g; intestinal digesta: 5 min, 8000 g). The supernatant and pellet fractions were separated and weighed. The pH of the supernatant fraction was measured (Russell combination pH electrode, Type RS-53, Auchtermuchty, Fife). The stomach supernatant fraction was then diluted twice in a 0-2 M-HC1 solution, mixed, centrifuged (5 min, 8000 g) and Fe was determined in the supernatant fraction. The proximal intestinal supernatant fraction was diluted fivefold with a 0-2 M-HC1 solution. The mixture was centrifuged (5 min, 8000 g) and Fe was determined in the supernatant fraction. The pellet was freeze-dried, weighed, dry-ashed (17 h, 500°), dissolved in 6 M-HC1, and brought to a final concentration of 1 -2 M-HC1 with demineralized water. Because of the minute amounts of sample, Fe was determined using a commercial kit (Iron FZ Test, Roche, Hoffmann La Roche & Co Ltd, Diagnostica, Basle, Switzerland) on a COBAS-BIO auto-analyser (Hoffmann-La Roche BV, Mijdrecht, The Netherlands) instead of using flame absorption spectrometry. The results of the two methods had been found earlier to correlate well (r 0-88; P = 001). Correlations were made for the amount of supernatant fraction that was still present in the pellet fraction before dry-ashing. Supernatant and freeze-dried pellet fractions of the digesta are referred to as liquid and solid phases of the digesta respectively.
Immediately after the rats had been killed, livers were removed, rinsed in saline (9 g NaCl/1) to remove blood, patted dry, weighed and frozen at -20° until analysis. A portion of liver (about 2 g) was dried overnight (105°), dry-ashed (17 h, 500°), dissolved in 6 M-HC1, and Fe was determined using flame atomic absorption spectrometry. 59 Fe uptake ratio is defined as mucosal calculations are described in detail by Marx (1979 
Statistical analysis
Results are presented as means with their standard errors. All data were found to be normally distributed according to the Kolmogorov-Smirnov one-sample test, with P = 005 as cut-off value. Student's t test was used for comparisons between the control and ascorbic-acid groups. The level of significance was pre-set at P < 0-05. All statistical analyses were conducted with the use of SPSS/PC+ software (Statistical Package for the Social Sciences, 1988).
RESULTS

Growth, feed and water intake
Mean body weight at day 0 was 145 (SE 4) g (n 16). Feed and water intakes, body-weight gain and final liver weight did not differ significantly between the two groups. Mean feed intake was 110 (SE 20) g/d (n 16), water intake was 14 (SE 1) ml/d, body-weight gain (days 0-15) was 34-2 (SE 20) g/15 d, and liver weight at day 15 was 33-7 (SE 0-3) g/kg body weight.
Iron status
All rats had anaemia after they had been fed on the pre-experimental diet for 4 weeks: mean blood Hb level was 4-3 (SE 01) mmol/1 (69 g/1) (n 16). After 2 weeks on the experimental diets both groups showed a recovery from the anaemia. There was no significant difference between the control and ascorbic-acid groups, their mean Hb values being 9-4 (SE 0-1) and 9-3 (SE 0-1) mmol/1 (« 8). Likewise, the Fe content of liver was not influenced by ascorbic acid addition to the diet. Hepatic Fe concentrations were 361 (SE 28) and 447 (SE 86) ug/g dry weight (n 8) for the control and test groups respectively.
Iron balance
Fe intake, faecal excretion and apparent absorption are listed in Table 2 . Apparent Fe absorption was high during days 5-7, but had declined after 12-14 d. During the first period, apparent Fe absorption was significantly increased by ascorbic acid, resulting in a lower faecal Fe excretion. During days 12-14, there was no longer a significant effect of ascorbic acid. Fe retention of 810 % in control rats, indicating that all Fe taken up by the mucosa was retained (Table 3 ). The rats given ascorbic acid showed a significantly higher mucosal uptake and retention of 59 Fe, but mucosal transfer was unaltered. At day 15 (7 d after administration), 51 Cr retention was 2-8 (SE 0-2) and 3-9 (SE 0-6) % of the administered dose for the control and ascorbic-acid groups respectively. This difference was not statistically significant.
Iron solubility in digesta
Neither in the stomach nor in the proximal half of the small intestine did we find group differences in Fe contents of the solid and liquid digesta fractions (Table 4) . Likewise, the Fe concentration of the liquid phase, an index of Fe solubility, did not differ between the control and test rats. The liquid contents of the stomach had a lower pH when ascorbic acid was fed, but no difference was seen in the proximal intestine. The relative amount of solid phase in the stomach contents was higher than in the intestinal contents. Possibly, the difference relates to sample preparation. Because of the high viscosity, the stomach contents had to be centrifuged longer and faster than the intestinal contents. Thus, we did not compare Fe concentrations in stomach and intestinal contents.
DISCUSSION
As would be expected, the feeding of ascorbic acid significantly raised the efficiency of Fe absorption. Apparent Fe absorption was significantly enhanced by ascorbic acid between days 5 and 7 after Fe repletion.
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Fe retention, which essentially equals Fe absorption, was significantly enhanced, also, by dietary ascorbic acid. The percentage apparent Fe absorption between days 5 and 7 was slightly higher than the percentage 59 Fe retention as based on a single dose administered on day 8. The difference in values for the two absorption measurements relates to the improvement of Fe status in the course of the experimental period when Fe sufficient diets were fed. It is known that an increase in Fe status leads to a decrease in Fe absorption, which is reflected also by the lower apparent Fe absorption during days 12-14, when compared with days 5-7. The feeding of ascorbic acid did not significantly raise apparent Fe absorption between days 12 and 14, but this may be attributed to the substantial inter-individual variation. Unexpectedly, ascorbic acid ingestion did not produce higher Hb and hepatic Fe concentrations. Ascorbic acid may have increased the initial rates by which Hb and hepatic Fe increased during Fe repletion without affecting the final values. The rats were given, daily, about 0-43 g ascorbic acid/kg metabolic weight, which is equivalent to a daily intake of about 10 g in man, this amount being about 160 times higher than the recommended dietary allowance. Daily supplementation with 1-5 g ascorbic acid leads to significantly higher Hb gain in Fe-depleted humans (Hunt et al. 1990) . Thus, our rats only showed a small response to dietary ascorbic acid when compared with humans, which confirms earlier work (Reddy & Cook, 1991) . The hyporesponsiveness of rats to ascorbic acid may relate to their capacity to synthesize ascorbic acid. In a rat strain lacking ascorbic-acidsynthesizing capacity, Fe absorption was strongly enhanced after addition of ascorbic acid to the diet (Reddy & Cook, 1994) .
The anaemic-rat model has an intrinsic, high efficiency of Fe absorption so that any modulation by a dietary factor can be easily masked. By exposure of the rat model to a high amount of ascorbic acid it was possible to raise Fe absorption which in turn allowed us to study the mechanism underlying the effect of ascorbic acid. Ascorbic acid is thought to increase Fe absorption because of its reducing properties (Bothwell et al. 1979; Barrand et al. 1990) , by which it converts and keeps Fe in the ferrous state. Dietary ferrous v. ferric Fe elevates the concentration of Fe in the liquid phase of the digesta and therefore is more available for absorption (Van Gils et al. 1994) . In the present study, using diets supplemented with FeSO 4 , the feeding of ascorbic acid did not affect the concentration of Fe in the liquid phase of contents of the proximal intestine. Apparently, in the control situation there were already sufficient ligands retaining the Fe in the soluble phase so that additional reducing capacity in the form of ascorbic acid had no effect. The observed increase in Fe absorption in rats given ascorbic acid, when compared with the high values in the control rats, appears to be independent of the solubility of Fe in the digesta. The rats were given purified diets. If natural-ingredient diets had been used ascorbic acid could have had an additional effect by counteracting components that inhibit Fe absorption by reducing Fe solubility in the digesta. In vitro, ascorbic acid has been shown to antagonize the inhibitory effect of soyabean-protein isolate on Fe solubilization (Rizk & Clydesdale, 1983) . In man, ascorbic acid consumption counteracted the inhibitory effect of phytate on Fe absorption (Hallberg et al. 1989) .
It has been demonstrated, using rabbit duodenal microvillous membrane vesicles, that ferric Fe may bind to the membrane but is not transported, whereas ferrous Fe, in the form of ferrous ascorbate, is readily transported (Marx & Aisen, 1981) . There is evidence that the mucosal cell itself provides the reducing capacity to allow transport of Fe, in the ferrous form, across the microvillous membrane. This reducing capacity for Fe may be enhanced in Fe deficiency as indicated by the increased Fe transport across brush-border membranes isolated from Fe-deficient mice (Muir et al. 1984) . Stremmel et al. (1987) identified, in rat duodenal microvillous membrane vesicles, a 52 kDa Fe-transport protein, possibly a reductase, that may function as a carrier for Fe. Thus, even at maximum induction of the reducing capacity of the mucosal cells, ascorbic acid is able to enhance Fe uptake. As stated earlier, ascorbic-acid feeding did not raise the amount of soluble Fe, i.e. the amount of Fe available for uptake through the microvillous mucosal membrane. It is possible that ascorbic acid acts directly at the level of the membrane. Alternatively, ascorbic acid could influence the form of soluble Fe. Fe in the liquid phase of the digesta consists of ferrous and ferric Fe species (Wollenberg & Rummel, 1987; Simpson & Peters, 1990) . Possibly, in the ascorbic-acid-fed group there was a higher proportion of ferrous Fe, but the total amount of soluble Fe in the digesta was not affected.
The Fe absorption process can be divided into mucosal uptake, i.e. transport across the microvillous membrane of mucosal cells, and mucosal transfer, i.e. transport through the mucosal cytoplasm and across the basolateral plasma membrane into the plasma (Manis & Schachter, 1962; Marx, 1979 Cr, as a nonabsorbable marker, we determined mucosal uptake and transfer of Fe. Ascorbic acid loading was found to stimulate mucosal Fe uptake, but there was no effect of ascorbic acid on mucosal Fe transfer. It is not possible to observe any stimulatory effect of ascorbic acid on intramucosal Fe handling or Fe transport across the basolateral plasma membrane as this Fe transport is already maximal in Fe deficiency. Studies using adult rats with a high Fe status may reveal an effect of ascorbic acid on mucosal Fe transfer, if any. This study was supported by Unilever Research Laboratorium, Vlaardingen, The Netherlands, through grant PAD 90-66 of the Dutch Platform for Alternatives to Animal Experiments.
